Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Verdoia

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 17, 2018
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventionsMonica Verdoia, Claudia Ceccon, Matteo Nardin, et al.
Coronary Artery Disease|October 14, 2017
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserveGiuseppe De Luca, Monica Verdoia, Lucia Barbieri, et al.
Thrombosis Research|March 17, 2015
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trialsMonica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
Coronary Artery Disease|January 20, 2021
Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessmentMonica Verdoia, Rocco Gioscia, Harry Suryapranata, et al.
Vascular Pharmacology|January 1, 2021
Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trialsMonica Verdoia, Stefano Savonitto, Dariusz Dudek, et al.
Giornale Italiano Di Cardiologia (2006)|March 26, 2015
[Two catheters for one coronary perforation]Lucia Barbieri, Monica Verdoia, Alon Schaffer, et al.
Current Vascular Pharmacology|June 7, 2024
Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary InterventionsMonica Verdoia, Matteo Nardin, Rocco Gioscia, et al.
Revista Espanola De Cardiologia (English Ed.)|July 24, 2017
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysisMonica Verdoia, Lucia Barbieri, Matteo Nardin, et al.
International Journal of Cardiology|August 29, 2018
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort studyMonica Verdoia, Matteo Nardin, Federica Negro, et al.
Angiology|April 18, 2018
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting StentsMonica Verdoia, Lucia Barbieri, Elvin Kedhi, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 17, 2018
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventionsMonica Verdoia, Claudia Ceccon, Matteo Nardin, et al.
Coronary Artery Disease|October 14, 2017
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserveGiuseppe De Luca, Monica Verdoia, Lucia Barbieri, et al.
Thrombosis Research|March 17, 2015
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trialsMonica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
Coronary Artery Disease|January 20, 2021
Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessmentMonica Verdoia, Rocco Gioscia, Harry Suryapranata, et al.
Vascular Pharmacology|January 1, 2021
Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trialsMonica Verdoia, Stefano Savonitto, Dariusz Dudek, et al.
Giornale Italiano Di Cardiologia (2006)|March 26, 2015
[Two catheters for one coronary perforation]Lucia Barbieri, Monica Verdoia, Alon Schaffer, et al.
Current Vascular Pharmacology|June 7, 2024
Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary InterventionsMonica Verdoia, Matteo Nardin, Rocco Gioscia, et al.
Revista Espanola De Cardiologia (English Ed.)|July 24, 2017
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysisMonica Verdoia, Lucia Barbieri, Matteo Nardin, et al.
International Journal of Cardiology|August 29, 2018
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort studyMonica Verdoia, Matteo Nardin, Federica Negro, et al.
Angiology|April 18, 2018
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting StentsMonica Verdoia, Lucia Barbieri, Elvin Kedhi, et al.
Pageof 20